Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Drilon

Showing results (51-60 of 268) with videos related to

Pageof 27
Sort By:
Oncology (Williston Park, N.Y.)|December 9, 2010
Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?Benjamin P Levy, Alexander Drilon, Liana Makarian, et al.
Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
JTO Clinical and Research Reports|February 20, 2026
ALK Inhibitor Response in Novel <i>ZFPM2::ALK</i> and <i>TRIM24::ALK</i> Fusion-Positive Lung Cancers: Case ReportCharles Hsu, Mohamed Yakoub, Michael Offin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2023
Response to Provenzano et al. and De Carlo et alOr Kalchiem-Dekel, Christine M Bestvina, Justin F Gainor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Learning All That We Can From MyPathwayJessica J Tao, Alison M Schram, James J Harding, et al.
Future Oncology (London, England)|January 6, 2023
Testing methods to diagnose TRK fusion cancer - a plain language summary and patient perspectiveErin R Rudzinski, Alexander Drilon, Amy Moore, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profilesNatasha Rekhtman, Laetitia Borsu, Boris Reva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2025
Seizure-Related Homolog Protein 6 (SEZ6): Biology and Therapeutic Target in Neuroendocrine CarcinomasEmelie Gezelius, Natasha Rekhtman, Marina K Baine, et al.
JCO Precision Oncology|December 31, 2020
Genomic Characterization of a RET Inhibitor-Resistant <i>RET</i> Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based SequencingNoura J Choudhury, Soo-Ryum Yang, Maria Arcila, et al.
Current Oncology Reports|March 18, 2017
Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to TherapyJoshua K Sabari, Fernando Santini, Isabella Bergagnini, et al.
Pageof 27

Showing results (51-60 of 268) with videos related to

Sort By:
Pageof 27
Oncology (Williston Park, N.Y.)|December 9, 2010
Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?Benjamin P Levy, Alexander Drilon, Liana Makarian, et al.
Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
JTO Clinical and Research Reports|February 20, 2026
ALK Inhibitor Response in Novel <i>ZFPM2::ALK</i> and <i>TRIM24::ALK</i> Fusion-Positive Lung Cancers: Case ReportCharles Hsu, Mohamed Yakoub, Michael Offin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2023
Response to Provenzano et al. and De Carlo et alOr Kalchiem-Dekel, Christine M Bestvina, Justin F Gainor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Learning All That We Can From MyPathwayJessica J Tao, Alison M Schram, James J Harding, et al.
Future Oncology (London, England)|January 6, 2023
Testing methods to diagnose TRK fusion cancer - a plain language summary and patient perspectiveErin R Rudzinski, Alexander Drilon, Amy Moore, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profilesNatasha Rekhtman, Laetitia Borsu, Boris Reva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2025
Seizure-Related Homolog Protein 6 (SEZ6): Biology and Therapeutic Target in Neuroendocrine CarcinomasEmelie Gezelius, Natasha Rekhtman, Marina K Baine, et al.
JCO Precision Oncology|December 31, 2020
Genomic Characterization of a RET Inhibitor-Resistant <i>RET</i> Fusion-Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture-Based SequencingNoura J Choudhury, Soo-Ryum Yang, Maria Arcila, et al.
Current Oncology Reports|March 18, 2017
Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to TherapyJoshua K Sabari, Fernando Santini, Isabella Bergagnini, et al.
Pageof 27